サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434608

人工膵臓デバイスシステム市場：デバイスタイプ、治療タイプ、エンドユーザー別-2024-2030年の世界予測

Artificial Pancreas Device System Market by Device Type (Control-to-Range System, Control-to-Target System, Threshold Suspended Device System), Treatment Type (Bi-Hormonal, Hybrid, Insulin Only), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
人工膵臓デバイスシステム市場：デバイスタイプ、治療タイプ、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工膵臓デバイスシステム市場規模は2023年に2億4,822万米ドルと推定され、2024年には2億9,766万米ドルに達すると予測され、CAGR 20.01%で2030年には8億8,996万米ドルに達する見込みです。

人工膵臓デバイスシステムの世界市場

主な市場の統計
基準年[2023］ 2億4,822万米ドル
予測年[2024] 2億9,766万米ドル
予測年 [2030] 8億8,996万米ドル
CAGR（%） 20.01%
人工膵臓デバイスシステム Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは人工膵臓デバイスシステム市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、人工膵臓デバイスシステム市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-人工膵臓デバイスシステム市場の市場規模および予測は？

2-人工膵臓デバイスシステム市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-人工膵臓デバイスシステム市場における技術動向と規制の枠組みは？

4-人工膵臓デバイスシステム市場における主要ベンダーの市場シェアは？

5-人工膵臓デバイスシステム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ライフスタイルの変化と高齢者人口による糖尿病有病率の上昇
      • 可処分所得の増加と糖尿病管理の選択肢に対する意識の向上
      • 膵臓がんの蔓延と血糖管理の自動化システムの需要
    • 抑制要因
      • 人工膵臓装置システムのコストが高い
    • 機会
      • この分野の研究開発への投資の拡大
      • 治療の質を向上させるための政府や組織からの資金の利用可能性
    • 課題
      • スポーツ糖尿病を治療するシステムの無力
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 人工膵臓デバイスシステム市場デバイスタイプ別

  • コントロールツーレンジシステム
  • コントロールからターゲットへのシステム
  • しきい値一時停止デバイスシステム

第7章 人工膵臓デバイスシステム市場治療タイプ別

  • バイホルモン
  • ハイブリッド
  • インスリンのみ

第8章 人工膵臓デバイスシステム市場：エンドユーザー別

  • 病院
  • 調査

第9章 南北アメリカの人工膵臓デバイスシステム市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の人工膵臓デバイスシステム市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの人工膵臓デバイスシステム市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Admetsys
    • Beta Bionics, Inc.
    • Bigfoot Biomedical, Inc.
    • Defymed
    • Dexcom, Inc.
    • Diabeloop SA
    • DreaMed Diabetes Ltd.
    • EOFlow Co., Ltd.
    • Glooko, Inc.
    • Insulet Corporation
    • Johnson & Johnson Services, Inc.
    • Medtronic PLC
    • PharmaCyte Biotech, Inc.
    • Tandem Diabetes Care, Inc.
    • Vertex Pharmaceuticals Incorporated
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-RANGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-TARGET SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY THRESHOLD SUSPENDED DEVICE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY BI-HORMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN ONLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET LICENSE & PRICING
目次
Product Code: MRR-4369010658AF

[191 Pages Report] The Artificial Pancreas Device System Market size was estimated at USD 248.22 million in 2023 and expected to reach USD 297.66 million in 2024, at a CAGR 20.01% to reach USD 889.96 million by 2030.

Global Artificial Pancreas Device System Market

KEY MARKET STATISTICS
Base Year [2023] USD 248.22 million
Estimated Year [2024] USD 297.66 million
Forecast Year [2030] USD 889.96 million
CAGR (%) 20.01%
Artificial Pancreas Device System Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Pancreas Device System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Pancreas Device System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Pancreas Device System Market, highlighting leading vendors and their innovative profiles. These include Admetsys, Beta Bionics, Inc., Bigfoot Biomedical, Inc., Defymed, Dexcom, Inc., Diabeloop SA, DreaMed Diabetes Ltd., EOFlow Co., Ltd., Glooko, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, PharmaCyte Biotech, Inc., Tandem Diabetes Care, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Artificial Pancreas Device System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Device Type
    • Control-to-Range System
    • Control-to-Target System
    • Threshold Suspended Device System
  • Treatment Type
    • Bi-Hormonal
    • Hybrid
    • Insulin Only
  • End-User
    • Hospitals
    • Research Institute
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Pancreas Device System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Pancreas Device System Market?

3. What are the technology trends and regulatory frameworks in the Artificial Pancreas Device System Market?

4. What is the market share of the leading vendors in the Artificial Pancreas Device System Market?

5. Which modes and strategic moves are suitable for entering the Artificial Pancreas Device System Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Pancreas Device System Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes due to changing lifestyle and elderly population
      • 5.1.1.2. Increase in disposable income and awareness on options to manage diabetes
      • 5.1.1.3. Prevalence of pancreatic cancer and demand for automated systems for glycemic control
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of artificial pancreas device systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in research and development in the field
      • 5.1.3.2. Availability of funds from the governments and organizations to improve the quality of treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Inability of the system to treat athletic diabetes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Pancreas Device System Market, by Device Type

  • 6.1. Introduction
  • 6.2. Control-to-Range System
  • 6.3. Control-to-Target System
  • 6.4. Threshold Suspended Device System

7. Artificial Pancreas Device System Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Bi-Hormonal
  • 7.3. Hybrid
  • 7.4. Insulin Only

8. Artificial Pancreas Device System Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Research Institute

9. Americas Artificial Pancreas Device System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Pancreas Device System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Pancreas Device System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Admetsys
    • 13.1.2. Beta Bionics, Inc.
    • 13.1.3. Bigfoot Biomedical, Inc.
    • 13.1.4. Defymed
    • 13.1.5. Dexcom, Inc.
    • 13.1.6. Diabeloop SA
    • 13.1.7. DreaMed Diabetes Ltd.
    • 13.1.8. EOFlow Co., Ltd.
    • 13.1.9. Glooko, Inc.
    • 13.1.10. Insulet Corporation
    • 13.1.11. Johnson & Johnson Services, Inc.
    • 13.1.12. Medtronic PLC
    • 13.1.13. PharmaCyte Biotech, Inc.
    • 13.1.14. Tandem Diabetes Care, Inc.
    • 13.1.15. Vertex Pharmaceuticals Incorporated
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing